The FDA has approved several radiopharmaceuticals for clinical use
FDA-Approved Radiopharmaceuticals

Technetium-99m Succimer in Nuclear Medicine: NephroSan for Scintigraphic Evaluation of Renal Function

Technetium-99m succimer is pivotal for renal imaging, enhancing diagnostics with minimal invasiveness and low radiation.

Technetium-99m Succimer in Nuclear Medicine: NephroSan for Scintigraphic Evaluation of Renal Function Read Article »

, ,